Toronto - Delayed Quote CAD

TerrAscend Corp. (TSND.TO)

0.6600 -0.0300 (-4.35%)

At close: October 30 at 3:49:57 PM EDT

Chart Range Bar

Loading chart for TSND.TO

Previous Close 0.6900
Open 0.6900
Bid 0.6600 x --
Ask 0.6700 x --
Day's Range 0.6500 - 0.6900
52 Week Range 0.5300 - 2.0000
Volume 342,594
Avg. Volume 194,167
Market Cap (intraday) 245.961M
Beta (5Y Monthly) 2.17
PE Ratio (TTM) --
EPS (TTM) -0.1500
Earnings Date Nov 5, 2026
Forward Dividend & Yield -- (0.00%)
Ex-Dividend Date --
1y Target Est 1.86

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries under the Apothecarium brand name. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

www.terrascend.com

828

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

TSND.TO

33.33%

S&P/TSX Composite index (^GSPTSE)

11.78%

1-Year Return

TSND.TO

30.53%

S&P/TSX Composite index (^GSPTSE)

18.03%

3-Year Return

TSND.TO

69.01%

S&P/TSX Composite index (^GSPTSE)

88.90%

5-Year Return

TSND.TO

90.96%

S&P/TSX Composite index (^GSPTSE)

69.32%

Earnings Per Share

gaap GAAP

nongaap Normalized

gaap GAAP

nongaap Normalized

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY26

Revenue 67.12M

Earnings -9.16M

Profit Margin -13.65%

FY25

FY26

-20M

20M

40M

60M

-30.0%

-20.0%

-10.0%

0.0%

Analyst Price Targets

1.49

1.86 Average

0.6600 Current

2.24 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Latest Rating

Date 3/17/2023

Analyst Needham

Rating Action Reiterates

Rating Buy

Price Action Announces

Price Target 1.75

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

-15.72%
Return on Assets (ttm)

4.99%
Return on Equity (ttm)

-26.98%
Revenue (ttm)

263.91M
Net Income Avi to Common (ttm)

-31.79M
Diluted EPS (ttm)

-0.1500

Balance Sheet and Cash Flow

Total Cash (mrq)

42.12M
Total Debt/Equity (mrq)

289.87%
Levered Free Cash Flow (ttm)

20.94M

CURA.TO Curaleaf Holdings, Inc.

11.77 -2.97%

VRNO.NE Verano Holdings Corp.

6.93 -4.81%

CL.CN Cresco Labs Inc.

0.8000 -5.88%

GTII.CN Green Thumb Industries Inc.

8.70 -3.33%

TSNDF TerrAscend Corp.

0.4800 -3.03%

U.S. markets closed

TerrAscend Corp. (TSND.TO)

0.00%

-13.16%

-36.54%

-33.33%

-30.53%

-90.96%

-51.11%

TerrAscend Corp. Overview Drug Manufacturers - Specialty & Generic / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Latest Rating

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch